Equifax Inc. (EFX) Pops 3.67% for February 12

Equities Staff |

One of the S&P 500’s big winners for Friday February 12 was Equifax Inc. (EFX) as the company’s stock climbed 3.67% to $96.88 on volume of 956,161 shares.

The stock opened at $95.30 and saw an intraday low of $95.30 and an intraday high of $99.14. All told, the day saw a per-share gain of $3.43. The stock’s average daily volume of 774,156 and 118.48 million shares outstanding. Equifax Inc. now has a 50-day SMA is $106.46 and 200-day SMA is $102.16, and it has a 52-week high of $114.46 and a 52-week low of $87.21.

Equifax Inc provides information solutions and human resources business process outsourcing services for businesses and consumers.

Based out of Atlanta, GA, Equifax Inc. has 7,500 employees and, after today’s trading, reached a market cap of $11.48 billion. The stock’s P/E Ratio is 26.3. Its P/S ratio is 4.16, P/B ratio is 5.15, and P/FCF ratio is 24.6.

For a complete fundamental analysis analysis of Equifax Inc., check out Equities.com’s Stock Valuation Analysis report for EFX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…